Genex Pharmaceutical Profit Margin

Genex Pharmaceutical's profit margin stands at 10.58% as of December 2007. That compares with 25.39% in the prior-year period — down 58.3% year over year. That is below the sector sector average of 13.16%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Genex Pharmaceutical reported 10.58% in profit margin versus 25.39% a year earlier — a 58.3% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Genex Pharmaceutical sits lower the its sector benchmark (13.16%) with a profit margin of 10.58%. That is roughly 19.6% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 10.58% for Genex Pharmaceutical means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Genex Pharmaceutical's profit margin evolved across reporting periods, while the comparison chart places GENX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.